Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Alcohol consumption and smoking may raise risk of upper aero-digestive tract cancers

This paper provides an extensive analysis of the proportion of the risk of upper aero-digestive tract (UADT) cancers in the population that may be due to alcohol consumption and/or smoking.

7 Sep 2011

Nasdaq OMX Stockholm approves EpiCept's request for primary listing of common stock

EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.

7 Sep 2011

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

OncoGenex Pharmaceuticals, Inc. announced today that data from two studies, a Phase II clinical study and a pre-clinical study, evaluating the investigational compound custirsen, were published in the September issues of the journals Clinical Cancer Research and Cancer Research.

7 Sep 2011

Breast cancer patients with BRCA1 mutation experience pCR after neoadjuvent chemotherapy

Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) - the disappearance of all evidence of disease from the breast tissue and lymph nodes - regardless of disease stage after standard neoadjuvent chemotherapy, according to new research from The University of Texas MD Anderson Cancer Center.

7 Sep 2011

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

7 Sep 2011

Walnuts may prevent breast cancer

A new study has found that eating a handful of walnuts on a regular basis may reduce women’s risk of developing breast cancer. Researchers from the Marshall University observed in mice that consuming 2 ounces of walnuts each day reduced the growth of breast cancer tumors.

6 Sep 2011

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

BioDelivery Sciences International, Inc. announced positive preliminary results from its Phase 1 study assessing the pharmacokinetics of a BEMA Buprenorphine/Naloxone formulation.

6 Sep 2011

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announces oral communication of the Phase II clinical trial results of its orphan product Livatag at the annual congress of ILCA, the only international organization devoted exclusively to liver cancer research with participation of worldwide best specialists.

6 Sep 2011

Mesoblast receives EMA clearance to initiate Revascor Phase 2 trial for heart attacks

Global regenerative medicine company, Mesoblast Limited, today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack.

5 Sep 2011

Asbestos related cancer risk rises after home renovations: Study

A third wave of asbestos-related cancers is emerging as the rate of malignant mesothelioma caused by exposure to asbestos during home renovations increases dramatically, according to new research.

5 Sep 2011

Pathology Visions Conference to be held at Manchester Grand Hyatt in San Diego

Mahul B. Amin, MD, chair of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, will offer his perspectives and expertise on personalized medicine and digital pathology at the 2011 Pathology Visions Conference.

3 Sep 2011

Researchers discover mechanisms behind BRCA1 gene mutations in breast and ovarian cancer

It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.

3 Sep 2011

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

SWOG has selected four talented, early-career researchers for its 2011 Young Investigator Training Course. These four will attend a three-day workshop September 19 - 21 in Seattle, Wash., for intensive training in how to design and conduct cancer clinical trials.

3 Sep 2011

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center at Jefferson testing its unique, two-step half-match procedure has produced some promising results: the probability of overall survival was 45 percent in all patients after three years and 75 percent in patients who were in remission at the time of the transplant.

2 Sep 2011

PTC restructures collaboration with Genzyme

PTC Therapeutics, Inc. and Genzyme, a Sanofi company, announced today the restructuring of their collaboration. Under the original agreement, PTC held commercial rights for the U.S. and Canada and Genzyme held commercial rights in all other countries.

2 Sep 2011

New genetic screening program for families at high risk of colorectal cancer

UT Southwestern Medical Center has developed a new lifesaving genetic screening program for families at high risk of contracting colorectal cancer, a deadly yet highly preventable form of cancer.

2 Sep 2011

Pemetrexed treatment produces better outcomes in ALK-translocated NSCLC patients

Patients with ALK-rearranged non-small cell lung cancer (NSCLC) responded significantly better to pemetrexed than patients whose cancer did not show ALK translocation, according to research published in the September issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer.

2 Sep 2011

Oncology News and Research

Further Reading

Alcohol consumption and smoking may raise risk of upper aero-digestive tract cancers

Nasdaq OMX Stockholm approves EpiCept's request for primary listing of common stock

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

Breast cancer patients with BRCA1 mutation experience pCR after neoadjuvent chemotherapy

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Walnuts may prevent breast cancer

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

Mesoblast receives EMA clearance to initiate Revascor Phase 2 trial for heart attacks

Asbestos related cancer risk rises after home renovations: Study

Pathology Visions Conference to be held at Manchester Grand Hyatt in San Diego

Researchers discover mechanisms behind BRCA1 gene mutations in breast and ovarian cancer

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

PTC restructures collaboration with Genzyme

New genetic screening program for families at high risk of colorectal cancer

Pemetrexed treatment produces better outcomes in ALK-translocated NSCLC patients

ASTRO's 53rd Annual Meeting to highlight new cancer advances in Miami

ACS' Commission on Cancer releases new standards to directly address patient concerns

RI Hospital researcher supports use of ablation procedures for treatment of lung cancer

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News